Savara ApS

Savara ApS focuses on clinical research in autoimmune pulmonary alveolar proteinosis, a rare interstitial lung disease marked by impaired clearance of surfactant within the lungs. The sponsor's studies are centered on respiratory disease management and the needs of patients affected by this uncommon pulmonary disorder.

• Autoimmune pulmonary alveolar proteinosis
• Rare lung disease
• Surfactant accumulation

Its research activity includes both adult and pediatric populations, reflecting interest in age-specific manifestations of the same underlying pulmonary condition.